Euretina highlights

Article

The 9th Euretina Congress took place during May in Nice, France and was attended, according to the organisers, by around 1700 delegates. This was a seminal event and will be the last of its kind as next year it will join forces with ESCRS (European Society of Cataract and Refractive Surgeons) in Paris from 2–8 September.

The 9th Euretina Congress took place during May in Nice, France and was attended, according to the organisers, by around 1700 delegates. This was a seminal event and will be the last of its kind as next year it will join forces with ESCRS (European Society of Cataract and Refractive Surgeons) in Paris from 2–8 September. The plan is to have separate scientific programmes and two joint symposia.

Across the three and a half days there were nine main sessions, free papers and 19 courses, the latter being well attended across the full three days. However, in talking to both exhibitors and delegates it was apparent that the feeling amongst many is that the number of shows taking place throughout the year is becoming prohibitvely expensive for the former and less attractive to the latter where time is often an issue.

Next year's event will take place in the most expensive exhibition space in the world, namely Paris, at Le Palais de Congres and will represent a considerable investment for all participants. Whilst undoubtedly a huge networking opportunity for doctors as several mentioned to OTEurope: "There are really now too many of these events and a week in Paris is stretching my practice's budget more than a little too far."

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.